Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Purell Hand Sanitizer for HSV-1 Lesions
NCT06135844Phase 1Unknown
- Start
- Apr 2022
- Primary completion
- Nov 2023
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of Purell Hand Sanitizer in herpes simplex labialis (2 arms). Primary endpoint: Duration of HSV-1 Lesion. Status: unknown.
02
Drugs
Purell Hand Sanitizer
03
Conditions
herpes simplex labialis
Beyond the preview
Go deeper on NCT06135844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06135844.